Benitec Biopharma Files 8-K: Material Agreement & Financials

Ticker: BNTC · Form: 8-K · Filed: Mar 26, 2025 · CIK: 1808898

Benitec Biopharma INC. 8-K Filing Summary
FieldDetail
CompanyBenitec Biopharma INC. (BNTC)
Form Type8-K
Filed DateMar 26, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, financials, corporate-action

TL;DR

Benitec Biopharma signed a big deal and filed financials on 3/25/25.

AI Summary

On March 25, 2025, Benitec Biopharma Inc. entered into a material definitive agreement. The company also reported on other events and filed financial statements and exhibits. The principal executive offices are located at 3940 Trust Way, Hayward, California.

Why It Matters

This filing indicates significant corporate activity, including a new material agreement and the submission of financial information, which could impact investor understanding of the company's current status and future prospects.

Risk Assessment

Risk Level: medium — The filing reports a material definitive agreement and financial statements, suggesting significant corporate actions that warrant investor attention and could carry inherent risks.

Key Players & Entities

FAQ

What type of material definitive agreement did Benitec Biopharma Inc. enter into?

The filing states that Benitec Biopharma Inc. entered into a 'Material Definitive Agreement' but does not specify the nature of the agreement in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on March 25, 2025.

Where are Benitec Biopharma Inc.'s principal executive offices located?

Benitec Biopharma Inc.'s principal executive offices are located at 3940 Trust Way, Hayward, California 94545.

What is the SIC code for Benitec Biopharma Inc.?

The Standard Industrial Classification (SIC) code for Benitec Biopharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.

What is the Commission File Number for Benitec Biopharma Inc.?

The Commission File Number for Benitec Biopharma Inc. is 001-39267.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 26, 2025 regarding Benitec Biopharma Inc. (BNTC).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing